KEYWORDS
Technology and Procedures, Assays, Molecular Testing, Omics Technologies, Pathology, Computational Biology, Profiling, Artificial Intelligence (AI), Machine Learning, Biological Processes, Genomics, Immune Mechanism, Diseases, Lymphoid Malignancies, Lymphomas, Measurable Residual Disease, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B Cell Lymphoma, Aggressive Lymphoma, Research, Fundamental Science, Translational Research, Clinical Research, Real-World Evidence, Study Population, Human, Adult, Pediatric, Young Adult